Xiaofu Qiu
Overview
Explore the profile of Xiaofu Qiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dong H, Lin W, Du L, Yao Z, Li F, Chen S, et al.
Cancer Lett
. 2023 Jun;
567:216283.
PMID: 37331584
Protein tyrosine phosphatase receptor-type O (PTPRO) is a membrane-bound tyrosine phosphatase. Notably, epigenetically silenced PTPRO due to promoter hypermethylation is frequently linked to malignancies. In this study, we used cellular...
12.
Zhang Y, Qiu X, Chen B
Urol Case Rep
. 2023 Jan;
46:102315.
PMID: 36713059
The case of penetrating injury of the kidney caused by a foreign body mistakenly swallowing through the duodenum is rare. A 22-year-old male patient found that a strip of the...
13.
Zheng Z, Guo Y, Huang X, Liu J, Wang R, Qiu X, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230788
As an important member of T cytotoxic pathway-related genes, CD8a molecule (CD8A) may be a useful biomarker of immunotherapeutic response and immune cell infiltration. We aimed to investigate the clinical...
14.
Wang Z, Dai Z, Wang B, Gao Y, Gao X, Wang L, et al.
Onco Targets Ther
. 2021 Aug;
14:4383-4389.
PMID: 34377000
Purpose: Prostate cancer is the second leading cause of cancer death in men worldwide. Olaparib is clinically approved for the treatment prostate cancer, but cytotoxicity and off-target effects including DNA...
15.
Zhang H, Qiu X, Yang G
Front Oncol
. 2021 Apr;
11:620126.
PMID: 33869003
The cysteine-serine-rich nuclear protein () family has prognostic value for various cancers. However, the association between this proteins and prognosis of clear cell renal cell carcinoma (ccRCC) remains unclear. This...
16.
Qiu X, Wang W, Li B, Cheng B, Lin K, Bai J, et al.
BMC Cancer
. 2019 Jan;
19(1):27.
PMID: 30621625
Background: Docetaxel was used to treat metastatic CRPC patients. However, Doc resistance in prostate cancer (PCa) hinders its clinical application. Objective: To understand the underlying mechanisms by which Doc resistance...
17.
Yang H, Chen B, Deng J, Zhuang G, Wu S, Liu G, et al.
Cell Tissue Res
. 2018 Aug;
374(2):303-315.
PMID: 30066105
Tissue-engineered urethra with autologous cells seeded on biodegradable scaffolds offers an alternative for lower urinary tract reconstruction. Rabbit is most commonly used as an animal model in urethra and bladder...
18.
Wang W, Yang C, Nie H, Qiu X, Zhang L, Xiao Y, et al.
Int J Cancer
. 2018 Jul;
144(6):1345-1355.
PMID: 30006972
LIM kinases modulate multiple aspects of cancer development, including cell proliferation and survival. As the mechanisms of LIMK-associated tumorigenesis are still unclear, we analyzed the tumorigenic functions of LIM kinase...
19.
Bai J, Yeh S, Qiu X, Hu L, Zeng J, Cai Y, et al.
Oncogene
. 2018 Jul;
37(44):5901-5912.
PMID: 29973687
While TR4 nuclear receptor plays key roles to promote prostate cancer progression, its roles to alter the progression of clear cell renal cell carcinoma (ccRCC), remains unclear. Here, we demonstrate...
20.
Cai Y, Zhang M, Qiu X, Wang B, Fu Y, Zeng J, et al.
Dis Markers
. 2017 Nov;
2017:8276939.
PMID: 29097832
Background And Objective: FBXW7, known as a general tumor suppressor, is commonly lowly expressed in metastatic malignancies. We aim to investigate the potential influence of FBXW7 overexpression on renal cell...